{"id":"https://openalex.org/W4407110222","doi":"https://doi.org/10.1016/s0022-3565(24)39003-2","title":"Dose- and Time-Dependent Bimodal Effects of \u03ba-Opioid Agonists on Locomotor Activity in Mice","display_name":"Dose- and Time-Dependent Bimodal Effects of \u03ba-Opioid Agonists on Locomotor Activity in Mice","publication_year":2000,"publication_date":"2000-12-01","ids":{"openalex":"https://openalex.org/W4407110222","doi":"https://doi.org/10.1016/s0022-3565(24)39003-2","mag":"2150153964","pmid":"https://pubmed.ncbi.nlm.nih.gov/11082438"},"language":"en","primary_location":{"id":"doi:10.1016/s0022-3565(24)39003-2","doi":"https://doi.org/10.1016/s0022-3565(24)39003-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)39003-2","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005988182","display_name":"Alexander Kuzmin","orcid":"https://orcid.org/0009-0007-4600-2414","observed_orcids":["https://orcid.org/0009-0007-4600-2414"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Alexander Kuzmin","raw_affiliation_strings":["Departments of Neuroscience (A.K., S.-O.O\u0308.) and Clinical Neuroscience (J.S., L.T.), Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neuroscience (A.K., S.-O.O\u0308.) and Clinical Neuroscience (J.S., L.T.), Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000443883","display_name":"Johan Sandin","orcid":"https://orcid.org/0000-0001-8385-456X","observed_orcids":["https://orcid.org/0000-0001-8385-456X"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Johan Sandin","raw_affiliation_strings":["Departments of Neuroscience (A.K., S.-O.O\u0308.) and Clinical Neuroscience (J.S., L.T.), Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neuroscience (A.K., S.-O.O\u0308.) and Clinical Neuroscience (J.S., L.T.), Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010768248","display_name":"Lars Y. Terenius","orcid":"https://orcid.org/0000-0003-2880-9576","observed_orcids":["https://orcid.org/0000-0003-2880-9576"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lars Terenius","raw_affiliation_strings":["Departments of Neuroscience (A.K., S.-O.O\u0308.) and Clinical Neuroscience (J.S., L.T.), Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neuroscience (A.K., S.-O.O\u0308.) and Clinical Neuroscience (J.S., L.T.), Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035523228","display_name":"Sven Ove \u00d6gren","orcid":"https://orcid.org/0000-0003-2573-5276","observed_orcids":["https://orcid.org/0000-0003-2573-5276"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sven-Ove \u00d6gren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005988182"],"corresponding_institution_ids":["https://openalex.org/I28166907"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.8148,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.68251606,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"295","issue":"3","first_page":"1031","last_page":"1042"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.7870000004768372},{"id":"https://openalex.org/keywords/kappa-opioid-receptor-agonists","display_name":"kappa opioid receptor agonists","score":0.8730000257492065},{"id":"https://openalex.org/keywords/u50-488h","display_name":"U50,488H","score":0.9010000228881836},{"id":"https://openalex.org/keywords/bremazocine","display_name":"bremazocine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.8539999723434448},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.8600000143051147},{"id":"https://openalex.org/keywords/motor-stimulation","display_name":"motor stimulation","score":0.7269999980926514},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.9369999766349792},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.675000011920929},{"id":"https://openalex.org/keywords/time-varying-effects","display_name":"time-dependent effects","score":0.8740000128746033},{"id":"https://openalex.org/keywords/nor-binaltorphimine","display_name":"nor-binaltorphimine","score":0.8939999938011169},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.8889999985694885},{"id":"https://openalex.org/keywords/beta-funaltrexamine","display_name":"beta-funaltrexamine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/dopamine-depletion","display_name":"dopamine depletion","score":0.921999990940094},{"id":"https://openalex.org/keywords/opioid-receptor-subtypes","display_name":"opioid receptor subtypes","score":0.6909999847412109},{"id":"https://openalex.org/keywords/habituation","display_name":"habituation","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C2993436365","wikidata":"https://www.wikidata.org/wiki/Q925958","display_name":"Locomotor activity","level":2,"score":0.7099851965904236},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6667587161064148},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.606776773929596},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4110981822013855},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.339202344417572},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2773303985595703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24466761946678162},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2380257248878479},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20260906219482422}],"mesh":[{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001575","descriptor_name":"Benzomorphans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D017879","descriptor_name":"Isothiocyanates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019900","descriptor_name":"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0022-3565(24)39003-2","doi":"https://doi.org/10.1016/s0022-3565(24)39003-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)39003-2","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:11082438","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11082438","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"mag:2150153964","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11082438","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1789439462","https://openalex.org/W1837577432","https://openalex.org/W1990106556","https://openalex.org/W1991432263","https://openalex.org/W1992989122","https://openalex.org/W2008023797","https://openalex.org/W2019174511","https://openalex.org/W2020898323","https://openalex.org/W2021514429","https://openalex.org/W2024978043","https://openalex.org/W2028296433","https://openalex.org/W2038401950","https://openalex.org/W2039757611","https://openalex.org/W2050829251","https://openalex.org/W2055994515","https://openalex.org/W2059703259","https://openalex.org/W2073833473","https://openalex.org/W2084886396","https://openalex.org/W2089486751","https://openalex.org/W2094146615","https://openalex.org/W2119488880","https://openalex.org/W2122283279","https://openalex.org/W2140257707","https://openalex.org/W2146476312","https://openalex.org/W2147107991","https://openalex.org/W2153710818","https://openalex.org/W2240690596","https://openalex.org/W2258774345","https://openalex.org/W2262406873","https://openalex.org/W2264583664","https://openalex.org/W2284089308","https://openalex.org/W4406969490"],"related_works":["https://openalex.org/W2150153964","https://openalex.org/W2041190297","https://openalex.org/W2094723953","https://openalex.org/W2442968712","https://openalex.org/W1989755623","https://openalex.org/W2166197577","https://openalex.org/W7004948637","https://openalex.org/W2072955127","https://openalex.org/W2094693957","https://openalex.org/W2016733882"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2025-02-04T00:00:00"}